BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Armandi A, Schattenberg JM. Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches. Nutrients 2021;13:1977. [PMID: 34201382 DOI: 10.3390/nu13061977] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang JJ, Wang DW, Peng YL, Cai D, Cheng YX. Spiroganodermaines A-G from Ganoderma species and their activities against insulin resistance and renal fibrosis. Phytochemistry 2022;202:113324. [PMID: 35931232 DOI: 10.1016/j.phytochem.2022.113324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Toth PP, Schwartz GG, Nicholls SJ, Khan A, Szarek M, Ginsberg HN, Johansson JO, Kalantar-zadeh K, Kulikowski E, Lebioda K, Wong NC, Sweeney M, Ray KK. Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease. American Journal of Preventive Cardiology 2022;11:100372. [DOI: 10.1016/j.ajpc.2022.100372] [Reference Citation Analysis]
3 Sabench F, Bertran L, Vives M, París M, Aguilar C, Martínez S, Binetti J, Real M, Alibalic A, Richart C, del Castillo D, Auguet T. NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity. OBES SURG. [DOI: 10.1007/s11695-022-06175-w] [Reference Citation Analysis]
4 Zhu YY, Meng XC, Zhou YJ, Zhu JX, Chang YN. Major royal jelly proteins alleviate non-alcoholic fatty liver disease in mice model by regulating disordered metabolic pathways. J Food Biochem 2022;:e14214. [PMID: 35510379 DOI: 10.1111/jfbc.14214] [Reference Citation Analysis]
5 André-dumont SI, Lanthier N. Quelle alimentation proposer aux patients présentant une stéatohépatite non-alcoolique ? Nutrition Clinique et Métabolisme 2022;36:12-20. [DOI: 10.1016/j.nupar.2021.11.001] [Reference Citation Analysis]
6 Gnoni A, Di Chiara Stanca B, Giannotti L, Gnoni GV, Siculella L, Damiano F. Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1/AMPK/PP2A Axis. Int J Mol Sci 2022;23:1044. [PMID: 35162967 DOI: 10.3390/ijms23031044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Lyalyukova EA, Druk IV, Dolgalev IV, Chernysheva EN, Loginova EN, Konovalova GM. Diet therapy in patients with metabolically associated fatty liver disease: what is the choice for particular patient? jour 2021. [DOI: 10.31146/1682-8658-ecg-194-10-109-117] [Reference Citation Analysis]
8 Formes H, Bernardes JP, Mann A, Bayer F, Pontarollo G, Kiouptsi K, Schäfer K, Attig S, Nikolova T, Hofmann TG, Schattenberg JM, Todorov H, Gerber S, Rosenstiel P, Bopp T, Sommer F, Reinhardt C. The gut microbiota instructs the hepatic endothelial cell transcriptome. iScience 2021;24:103092. [PMID: 34622147 DOI: 10.1016/j.isci.2021.103092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]